SKIP TO CONTENT
About Abbott
Contact
International | eng
Country Language

CARDIOVASCULAR

International | eng
Country Language

XIENCE™ Family of Drug-Eluting Stents

The World's Leading Drug-Eluting Stents (DES), with Unparalleled Clinical Outcomes¹

XIENCE™ Family of Drug-Eluting Stents
Excellent Deliverability

Excellent Deliverability with XIENCE Skypoint™ Stent2

The latest design elements, plus proven ability to deliver with previous generations of XIENCE™ Stents, provide excellent deliverability for interventional cardiologists (ICs) encountering challenging lesions.

Excellent Deliverability

Catheter Enhancements

Unlike prior generations of XIENCE™ Stent, XIENCE Skypoint™ Stent has a seamless one-piece catheter shaft that optimizes pushability.2 In addition, the guide wire notch profile is reduced by 0.001”.3

One piece comparison
Guidewire Notch

Excellent Deliverability

Data reveal excellent deliverability with XIENCE Skypoint™ Stent. This compares favorably with XIENCE Sierra™ Stent.4

Deliverability with XIENCE Skypoint Stent is 11% higher compared to XIENCE Sierra Stent.

Better Stent Retention

High stent retention helps prevent dislodgement and help ensure safe crossing, even when treating complex lesions. Testing reveals that XIENCE Skypoint™ Stent force is better than those of Synergy‡ and Resolute Onyx‡ DES, reaching statistical significance.5

XIENCE Skypoint Stent performs better in stent retention tests compared to Synergy and Resolute Onyx drug-eluting stents.

Lower Crossing Forces with XIENCE Skypoint™ Stent6

Lower crossing forces can also aid in optimizing stent deliverability. Note that XIENCE Skypoint™ Stent crossing forces are significantly lower than those of Synergy‡ and Resolute Onyx‡ DES.

The crossing forces with XIENCE Skypoint Stent are significantly lower compared to Synergy and Resolute Onyx DES.

When using the XIENCE Skypoint™ 48-mm Stent, the hypotube has a 33% increase in wall thickness.7

The crossing forces with XIENCE Skypoint Stent are significantly lower compared to Synergy and Resolute Onyx DES.

Excellent Push Efficiency with XIENCE Skypoint™ Stent8

Testing confirms better push efficiency, revealing a 5% improvement for XIENCE Skypoint™ Stent compared to XIENCE Xpedition™ Stent.

Push Efficiency–48 mm stents

Manuals & Technical Resources

Manuals & Technical Resources

Order Cardiovascular Products

Cardiovascular Products

Customer Service

Customer Service

References

  1. Zanchin C, et al. JACC Cardiovasc Interv. 2019;12(17):1665-1675. Serruys P, et al. N Engl J Med. 2010;363:136-146. Shiomi H, et al. JACC Cardiovasc Interv. 2019;12:637-647. Kufner S, et al. Circulation. 2019:139(3):325-333. Palmerini T, et al. Lancet. 2013;379:1393-1402. Bangalore S, et al. Circulation. 2012;125:2873-2891. Bangalore S, et al. Circ Cardiovasc Interv. 2013;6(6):378-390. Pilgrim T, et al. Lancet. 2014;384:2111-2122. Pilgrim T, et al. Lancet. 2018;392:737-746. Data on file at Abbott.
  2. Data on file at Abbott—XIENCE Skypoint™ Stent compared with XIENCE Sierra™ Stent.
  3. Data on file at Abbott—XIENCE Skypoint™ Stent Product Specification.
  4. Test performed by and data on file at Abbott—3.0 x 18 mm or 3.0 x 20 mm stents tested using a simulated arterial model.
  5. Tests performed by and data on file at Abbott. XIENCE Skypoint™ Stent (3.0 x 18 mm) n=5, SYNERGY‡ (3.0 x 20 mm) n=5, Resolute Onyx‡ (3.0 x 18 mm) n=5.
  6. Data on file at Abbott. XIENCE Skypoint™ Stent (3.0 x 18 mm) n=5, SYNERGY‡ (3.0 x 20 mm) n=5, Resolute Onyx‡ (3.0 x 18 mm) n=5.
  7. Data on file at Abbott. Hypotube wall thickness information—XIENCE Skypoint™ Stent 0.004ʺ compared with XIENCE Xpedition™ Stent 0.003ʺ.
  8. Data on file at Abbott. XIENCE Skypoint™ Stent compared with XIENCE Xpedition™ Stent – 3.0 x 48 mm stents tested.

MAT-2107573 v2.0

POLICIES & ADVISORIES
HEALTHCARE PROFESSIONALS
PATIENTS & CAREGIVERS
Abbott logo

Information contained herein for distribution outside the U.S. only.

CAUTION: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or online for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-2001111 v7.0

Disclaimer

You are about to enter an Abbott country- or region-specific website. 

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions

Do you wish to continue and enter this website? 

YES

MAT-2305078 v1.0